The Coe lab studies ways to improve medication use, health and well-being of older adults and the quality of care provided to them. We focus on identifying strategies and healthcare policies to improve transitions of care including medication management, particularly in older adults with Alzheimer’s disease, related dementias, and cognitive impairment.
- Transitions of care
The care transition from the hospital to home presents many challenges for older adults with complex medical needs, particulary those with Alzheimer's disease, related dementias, and cognitive impairment. Adverse outcomes are common, including potentially avoidable hospital readmissions and inappropriate medication use. Older adults are at an increased risk for experiencing health-related complications during this care transition due to factors such as cognitive decline, multiple comorbidities requiring numerous medications, and fragmented healthcare. We study the impact of policy on care transition quality.
- Medication-related outcomes and health services use
The Coe lab focuses on ways to improve medication use in older adults. We study the impact of Medicare Part D Medication Therapy Management, including annual comprehensive medication reviews, on safe and effective medication use. We examine how pharmacist-provided medication reviews can improve appropriate medication use in older adults in different settings, such as primary care, community-based settings, and in specialty clinics, and how this impacts health services use and quality of care.
In the News
Poll shows only 29% of adults who take five or more prescription drugs have had a comprehensive medication review.
Changes made to prescriptions during intensive care should be reassessed after discharge, study finds.